ELISA Kit
CN → US| HS编码 | 关税税率 | 原产国 | 目的国 | 文档 |
|---|---|---|---|---|
| 3006931000 | 10.0% | CN | US | 官方文档 |
| 3006938000 | 40.0% | CN | US | 官方文档 |
| 3002150091 | 10.0% | CN | US | 官方文档 |
| 3002140090 | 10.0% | CN | US | 官方文档 |
| 3822190080 | 10.0% | CN | US | 官方文档 |
商品图片
AI分析
🧪 ELISA Kit (Enzyme-Linked Immunosorbent Assay Kit)
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
📌 I. Product Definition & Classification: What Exactly is an "ELISA Kit"?
An ELISA Kit is a critical diagnostic tool used in clinical research, clinical trials, and laboratory settings. It typically consists of microtiter plates, reagents, buffers, and controls designed to detect the presence of specific antigens or antibodies in a sample.
In international trade, ELISA kits are often categorized based on their clinical trial status, material composition, and specific function:
- Clinical Trial Kits (Placebo/Blind): Used as part of a blinded study, packaged with drug formulations.
- Immunoassay Reagents: Based on biological or immunological principles (e.g., detecting antibodies).
- General Diagnostic/Chemical Reagents: Laboratory kits that do not fit strictly into immunological categories or contain mixed chemical components.
⚠️ Key Distinction Point:
- If the kit is explicitly a placebo or blind control for clinical trials → Consider 3006.93
- If it is a biological/immunological test → Consider 3002.15 / 3002.14
- If it is a general diagnostic/chemical reagent → Consider 3822.19
📦 II. HS Code Classification Details (2026 Latest Tariff Authority Mapping)
Based on the provided data, here are the 5 possible HS Codes for an ELISA Kit, along with their rationale and tax implications.
| HS Code | Product Description | Application Scenario | Rationale for Classification | Total Tax Rate |
|---|---|---|---|---|
3006.93.10.00 |
Clinical Trial Placebo/Blind Kit | Clinical trials, drug development | Acts as a placebo or blind test suite, packaged with drugs. No material conflict. Matches "medical supplies" logic. | 10.0% |
3006.93.80.00 |
Other Chemical Substances in Clinical Kits | General clinical trial kits | Contains chemical substances other than the drug itself. Based on common sense, ingredients are chemical preparations. | 40.0% |
3002.15.00.91 |
Other Immunoassays / Biological Preparations | Diagnostic tests for antibodies/antigens | ELISA is inherently an immunoassay. Common form of biological/immunological products. No material conflict. | 10.0% |
3002.14.00.90 |
Other Immunological Products | Specific immuno-logical diagnostics | ELISA kits are immunoassay tools. Since specific ingredients aren't defined, falls under "other" immunological items. No conflict. | 10.0% |
3822.19.00.80 |
Diagnostic/Laboratory Reagents | General lab diagnostics | Common format for diagnostic or lab reagents. Fits the category of "diagnostic or laboratory reagents." No material/use conflict. | 10.0% |
🔍 Critical Insight:
- 3006.93.10.00 is the most favorable if the kit is specifically for clinical trials as a placebo/blind tool.
- 3006.93.80.00 carries the highest tax (40%) due to additional duties. Avoid this unless the chemical nature is strictly defined and cannot be classified under immunological (3002) or general diagnostic (3822).
- 3002.15/3002.14 are strong candidates for immunological diagnostics (common for ELISA).
- 3822.19.00.80 is a safe fallback for general lab reagents if immunological classification is disputed.
💰 III. 2026 Latest Tariff Rate Breakdown (Including Additional Duties & Policy Surcharges)
✅ Applicable Country: United States (US)
✅ Origin: China (CN)
✅ Effective Date: From November 10, 2025 (and onwards)
🎯 1. 3006.93.10.00 — Clinical Trial Placebo/Blind Kit (Lowest Risk & Cost)
| Item | Details |
|---|---|
| Base Duty Rate | 0.0% |
| Section 301 (USITC) Surcharge | 0.0% |
| Section 122 (IEEPA) Surcharge | +10.0% |
| Total Effective Rate | 10.0% |
| Tax Calculation | CIF Value × 10% |
| De Minimis Eligibility | ❌ No (Likely subject to Section 321 limitations for certain medical/chemical items, but specifically highlighted as non-exempt in context) |
| Legal Basis Path | IEEPA:9903.01.25 → USITC:3006.93.10.00 → FOOTNOTE:122 |
📌 Explanation:
- Base Duty: 0% for medical/supplies in this subcategory.
- IEEPA 10%: Applies to Chinese-origin goods under international emergency economic powers.
- No Section 301: This specific sub-item benefits from a waiver or lower classification under current trade rules.
- Strategic Advantage: Lowest tax burden among all options. Ideal if the kit can be justified as a "clinical trial placebo" or "medical supply."
🎯 2. 3006.93.80.00 — Other Clinical Trial Kits (High Tax Warning)
| Item | Details |
|---|---|
| Base Duty Rate | 5.0% |
| Section 301 (USITC) Surcharge | +25.0% |
| Section 122 (IEEPA) Surcharge | +10.0% |
| Total Effective Rate | 40.0% |
| Tax Calculation | CIF Value × 40% |
| De Minimis Eligibility | ❌ No |
| Legal Basis Path | IEEPA:9903.01.25 → IEEPA:9903.01.24 → USITC:3006.93.80.00 → FOOTNOTE:9903.88.01 |
📌 Explanation:
- This code captures "other chemical substances" in clinical kits not otherwise specified.
- High Risk: Attracts all three taxes (Base + 301 + IEEPA).
- Avoidance Strategy: Only use if the product is explicitly a chemical reagent not fitting immunoassay (3002) or diagnostic reagent (3822) definitions.
🎯 3. 3002.15.00.91 & 3002.14.00.90 — Immunological Products (Moderate Tax, High Accuracy)
| Item | Details |
|---|---|
| Base Duty Rate | 0.0% |
| Section 301 (USITC) Surcharge | 0.0% |
| Section 122 (IEEPA) Surcharge | +10.0% |
| Total Effective Rate | 10.0% |
| Tax Calculation | CIF Value × 10% |
| De Minimis Eligibility | ❌ No |
| Legal Basis Path | IEEPA:9903.01.25 → USITC:3002.15.00.91 / 3002.14.00.90 |
📌 Explanation:
- ELISA is fundamentally an immunological test.
- These codes have 0% base duty and 0% Section 301, only subject to the 10% IEEPA surcharge.
- Strong Candidate: Highly recommended if the kit detects antibodies/antigens.
- Distinction:
-3002.15: Broader "other immunoassays."
-3002.14: "Other immunological products."
- Choose based on specific regulatory definitions; both yield the same 10% total tax.
🎯 4. 3822.19.00.80 — Diagnostic/Laboratory Reagents (Safe Fallback)
| Item | Details |
|---|---|
| Base Duty Rate | 0.0% |
| Section 301 (USITC) Surcharge | 0.0% |
| Section 122 (IEEPA) Surcharge | +10.0% |
| Total Effective Rate | 10.0% |
| Tax Calculation | CIF Value × 10% |
| De Minimis Eligibility | ❌ No |
| Legal Basis Path | IEEPA:9903.01.25 → USITC:3822.19.00.80 |
📌 Explanation:
- If the kit is not purely immunological (e.g., contains non-specific chemical reagents), this code applies.
- Same 10% total tax as immunological codes.
- Versatility: Useful if the product description emphasizes "diagnostic" or "lab reagent" over "immunoassay."
🛠️ IV. Customs Clearance Practical Advice (Avoiding Pitfalls)
✅ 1. Documentation Checklist (Non-Negotiable)
| Document | Mandatory? | Description |
|---|---|---|
| ✅ Product Specification Sheet | ✔️ | Must detail ingredients, intended use (clinical trial vs. diagnostic), and methodology. |
| ✅ Clinical Trial Protocol (if applicable) | ✔️ | If claiming 3006.93.10.00, provide proof it's used as a placebo/blind kit in a trial. |
| ✅ Ingredients List (COA) | ✔️ | Crucial for distinguishing between 3002 (immunological) and 3822 (chemical). |
| ✅ Commercial Invoice | ✔️ | Clearly state "ELISA Kit" and intended use. Avoid vague terms like "Chemical Reagent" if it's immunological. |
| ✅ Certificate of Origin | ✔️ | Required for IEEPA surcharge determination. |
| ✅ FDA Registration/Listing (if US-bound) | ✔️ | ELISA kits often require FDA 510(k) or exemption status. |
✅ 2. Classification Strategy (Key Mantra)
🔥 “Use defines Code, Immunology is 10%, Placebo is 10%, Chemical is 40%!”
| Scenario | Recommended HS Code | Tax Rate | Risk Level |
|---|---|---|---|
| Kit used as Placebo/Blind in Clinical Trials | 3006.93.10.00 |
10% | 🟢 Low |
| ELISA for Antibody/Antigen Detection (Immunoassay) | 3002.15.00.91 / 3002.14.00.90 |
10% | 🟢 Low |
| General Lab Diagnostic Reagent (Non-immunological) | 3822.19.00.80 |
10% | 🟢 Low |
| Clinical Kit with Unspecified Chemical Components | 3006.93.80.00 |
40% | 🔴 High |
⚠️ Critical Warning:
- Do NOT default to3006.93.80.00unless you are certain the product is a "chemical substance" not fitting immuno/diagnostic categories. The 30% tax difference is significant.
- ELISA is inherently immunological. Prefer3002codes unless you have strong evidence it's a non-immunological chemical test.
✅ 3. Special Circumstances Handling
| Situation | Handling Advice |
|---|---|
| OEM/Private Label Kits | Provide manufacturer’s certificate of analysis (COA) to prove immunological nature. |
| Mixed Contents (Reagents + Plates) | Declare as a complete kit. Do not split components; split declarations may trigger higher duties for each part. |
| Used for Research Only (Not Clinical) | Still eligible for 3002 or 3822 if intended for diagnostic-like detection. Clearly label "For Research Use Only" (RUO) if not FDA-cleared. |
| Origin: Non-China (e.g., Germany, USA) | IEEPA 10% surcharge does NOT apply. Tax rate drops to 0% (Base + 301 may still apply depending on product). |
🌍 V. Global Market Comparison (2026)
| Market | Recommended HS Code | Total Tax (China Origin) | Key Certification |
|---|---|---|---|
| 🇺🇸 United States | 3002.15.00.91 / 3006.93.10.00 |
10% (IEEPA only) | FDA 510(k) / Exemption |
| 🇪🇺 European Union | 3822.19 / 3002.90 |
0%~6.5% (VAT applies) | CE Marking, IVD Directive |
| 🇨🇳 China | 3822.19 / 3002.90 |
0%~5% | NMPA Registration |
| 🇯🇵 Japan | 3822.19 / 3002.90 |
0%~6% | PMDA Approval |
📌 Conclusion:
- US Market: Highest complexity due to IEEPA 10% surcharge. Avoid3006.93.80.00at all costs.
- EU/JP/CN: Lower tariffs, but stricter regulatory approvals (CE, PMDA, NMPA) for ELISA kits.
📌 VI. Common Errors & Pitfalls (Lessons Learned)
❌ Error 1: Classifying ELISA Kit as 3006.93.80.00
👉 Consequence: 40% tax instead of 10%. Huge cost increase.
✅ Fix: Prove immunological nature (3002) or clinical placebo use (3006.93.10).
❌ Error 2: Declaring as "Chemical Reagent" when it's Immunological
👉 Consequence: Misclassification risk, potential penalty, and loss of preferential rates.
✅ Fix: Use precise terms like "Immunoassay Kit" or "Antibody Detection Kit."
❌ Error 3: Ignoring IEEPA Surcharge
👉 Consequence: Underestimating landed cost by 10%.
✅ Fix: Always add 10% to base duty for Chinese-origin goods in these categories.
🎯 VII. Conclusion: Precision Classification, Cost Efficiency
🎯 Remember the Mantra:
🔹 "ELISA is Immuno: Use 3002, Pay 10%.
Placebo is Clinical: Use 3006.10, Pay 10%.
Avoid 3006.80, or Pay 40%!"
🔹 "HS Code Determines Profit; 30% Difference Can Break Your Margin!"
📌 Pro Tip:
If your ELISA Kit is originating from the EU, USA, or Japan, the IEEPA 10% surcharge is waived. Total tax may be 0% (depending on base rate and 301 applicability). Always verify origin!
📣 Immediate Action:
📞 Consult with a licensed customs broker.
📄 Submit a Product Composition Analysis to justify3002or3822classification.
🚀 Optimize your supply chain to leverage non-China origins if tax savings are critical.
✨ Professional Clearance Starts with Accurate Classification!
💼 Every Percentage Point of Tax Savings is Pure Profit!
用户评价
关于 HS 编码归类
协调制度(HS)是由世界海关组织(WCO)制定的国际贸易商品分类标准。全球 200 多个国家采用 HS 系统作为海关关税、贸易统计和进出口监管的基础。
每个 HS 编码遵循以下层级结构:
- 章(2 位)——商品大类(例如:第 84 章:机器和机械设备)
- 品目(4 位)——章内的更具体分类
- 子目(6 位)——国际通用细分,所有 WCO 成员国统一使用
- 本国细分(8-10 位)——各国自行扩展的细分编码,如美国 HTSUS 10 位编码
正确的 HS 编码归类对于顺利通关、准确缴纳关税和遵守贸易法规至关重要。错误归类可能导致海关延误、多缴关税或罚款。
从CN进口到US时,适用的关税税率可能包括:
- 最惠国(MFN)税率——适用于 WTO 成员国的标准关税税率
- 普通税率——适用于无贸易协定国家
- 贸易救济关税——附加关税,如 301 条款(反倾销)、232 条款(国家安全)或反补贴税
本页内容仅供参考。如需正式归类,请咨询当地海关或持牌报关代理。